Published in J Nerv Ment Dis on September 01, 1991
Subdomains within the negative symptoms of schizophrenia: commentary. Schizophr Bull (2006) 1.09
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci (2010) 0.98
The effects of early and sustained intervention on the long-term morbidity of schizophrenia. J Psychiatr Res (1998) 0.97
Improving outcome in schizophrenia: the case for early intervention. CMAJ (1999) 0.94
How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up. Schizophr Bull (2008) 0.94
Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
Is early intervention for psychosis feasible and effective? Psychiatr Clin North Am (2012) 0.91
Locus of control: relation to schizophrenia, to recovery, and to depression and psychosis -- A 15-year longitudinal study. Psychiatry Res (2009) 0.88
Negotiating risk: knowledge and use of HIV prevention by persons with serious mental illness living in supportive housing. Am J Community Psychol (2005) 0.87
Parenting an adult child with bipolar disorder in later life. J Nerv Ment Dis (2009) 0.85
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions. Neuropsychiatr Dis Treat (2007) 0.79
Effects of Psychopathology, Functioning and Anti-psychotic Medication Adherence on Caregivers' Burden in Schizophrenia. Indian J Psychol Med (2013) 0.78
Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut Lodge. Schizophr Bull (2007) 0.77
Smaller than expected cognitive deficits in schizophrenia patients from the population-representative ABC catchment cohort. Eur Arch Psychiatry Clin Neurosci (2015) 0.76
Empirically Based Psychosocial Therapies for Schizophrenia: The Disconnection between Science and Practice. Schizophr Res Treatment (2013) 0.75
Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy. Int J Ment Health Syst (2015) 0.75
The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders. NPJ Schizophr (2017) 0.75
Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med (1979) 4.87
The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull (1974) 2.25
The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry (1974) 2.20
The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry (1987) 2.19
Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry (1977) 1.81
The prediction of outcome in schizophrenia. I. Characteristics of outcome. Arch Gen Psychiatry (1972) 1.80
The course of psychiatric disorder, III: Longitudinal principles. Am J Psychiatry (1985) 1.80
The Vermont longitudinal study of persons with severe mental illness, I: Methodology, study sample, and overall status 32 years later. Am J Psychiatry (1987) 1.80
Intracutaneous injection of sebum and comedones. Histological observations. Arch Dermatol (1965) 1.77
Sustainable rates of sebum secretion in acne patients and matched normal control subjects. J Am Acad Dermatol (1983) 1.72
Sense of self in recovery from severe mental illness. Br J Med Psychol (1992) 1.71
Diagnostic criteria and five-year outcome in schizophrenia. A report from the International Pilot Study of schizophrenia. Arch Gen Psychiatry (1975) 1.70
Age-related changes in sebaceous gland activity. J Invest Dermatol (1979) 1.63
Effect of tetracycline on the composition of sebum in acne vulgaris. N Engl J Med (1965) 1.61
Hallucinations and delusions as points on continua function. Rating scale evidence. Arch Gen Psychiatry (1969) 1.59
Virtual microscopy: high resolution digital photomicrography as a tool for light microscopy simulation. Hum Pathol (1999) 1.54
Endocrinologic control of the development and activity of the human sebaceous gland. J Invest Dermatol (1974) 1.42
Anatomical variation in the amount and composition of human skin surface lipid. J Invest Dermatol (1970) 1.41
The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial. J Am Acad Dermatol (1980) 1.39
Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol (1984) 1.39
Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry (1973) 1.36
The effect of marked inhibition of sebum production with 13cis-retinoic acid on skin surface lipid composition. J Invest Dermatol (1980) 1.35
Chronicity in schizophrenia: revisited. Br J Psychiatry Suppl (1992) 1.32
Flexible system for the diagnosis of schizophrenia: report from the WHO International Pilot Study of Schizophrenia. Science (1973) 1.32
Cross-cultural evaluation of Schneider's first-rank symptoms of schizophrenia: a report from the International Pilot Study of Schizophrenia. Am J Psychiatry (1974) 1.23
Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol (1991) 1.22
The composition of the ceramides from human stratum corneum and from comedones. J Invest Dermatol (1985) 1.21
Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol (1983) 1.19
An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry (1981) 1.14
Chemical composition of human skin surface lipids from birth to puberty. J Invest Dermatol (1970) 1.14
The role of social relationships in the recovery from psychotic disorders. Am J Psychiatry (1984) 1.14
Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol (1979) 1.12
Self-control in psychotic disorders. Arch Gen Psychiatry (1983) 1.10
Isotretinoin revisited. Cutis (1988) 1.08
Characteristic symptoms and outcome in schizophrenia. Arch Gen Psychiatry (1974) 1.08
Recent advances in androgen metabolism and their relation to the skin. Arch Dermatol (1969) 1.07
Variability in the chemical composition of human skin surface lipids. J Invest Dermatol (1969) 1.06
Beyond the biopsychosocial model: integrating disorder, health, and recovery. Psychiatry (1995) 1.03
Essential fatty acids and acne. J Am Acad Dermatol (1986) 1.03
Signs and symptoms as predictors of outcome: a report from the International Pilot Study of Schizophrenia. Am J Psychiatry (1978) 1.02
Effect of ethinyloestradiol on plasma testosterone levels and urinary testosterone excretion in man. Acta Endocrinol (Copenh) (1965) 1.02
Human stratum corneum polar lipids and desquamation. Arch Dermatol Res (1985) 1.01
Another view of schizophrenia subtypes. A report from the international pilot study of schizophrenia. Arch Gen Psychiatry (1976) 0.99
Effect of orally administered antibacterial agents on titratable acidity of human sebum. J Invest Dermatol (1966) 0.99
Sebaceous gland suppression with ethinyl estradiol and diethylstilbestrol. Arch Dermatol (1973) 0.98
Octadecadienoic acids in the skin surface lipids of acne patients and normal subjects. J Invest Dermatol (1976) 0.98
The use of clustering techniques for the classification of psychiatric patients. Br J Psychiatry (1973) 0.98
Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response. Arch Dermatol (1980) 0.97
The effect of estrogen and androgen on the sebaceous gland turnover time. J Invest Dermatol (1969) 0.95
Effect of cyclic progestin-estrogen therapy on sebum and acne in women. JAMA (1980) 0.94
Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol (1982) 0.93
Beyond diagnosis: the phenomenology of schizophrenia. Am J Psychiatry (1981) 0.93
Changes in long-term sebum production from isotretinoin therapy. J Am Acad Dermatol (1982) 0.93
Congenital neural hamartoma ("fascicular schwannoma"). A light microscopic, immunohistochemical, and ultrastructural study. Am J Dermatopathol (1990) 0.92
Effect of oral 13-cis-retinoic acid at three dose levels on sustainable rates of sebum secretion and on acne. J Am Acad Dermatol (1983) 0.92
Chronicity in schizophrenia: fact, partial fact, or artifact? Hosp Community Psychiatry (1987) 0.91
The sebaceous glands: twenty-five years of progress. J Invest Dermatol (1976) 0.91
The treatment of acute schizophrenia without drugs: an investigation of some current assumptions. Am J Psychiatry (1977) 0.91
Sebaceous gland response in man to the administration of testosterone, delta-4-androstenedione, and dehydroisoandrosterone. J Invest Dermatol (1969) 0.90
Effect of prednisone on sebaceous gland secretion. J Invest Dermatol (1967) 0.90
New directions in diagnosis: the longitudinal processes of schizophrenia. Am J Psychiatry (1981) 0.89
The time course of lipid formation in human sebaceous glands. J Invest Dermatol (1977) 0.89
Do psychiatric patients fit their diagnoses? Patterns of symptomatology as described with the biplot. J Nerv Ment Dis (1979) 0.88
Premorbid adjustment in schizophrenia. Part II. Measuring premorbid adjustment: the instruments and their development. Schizophr Bull (1977) 0.88
Insight and interpretation of illness in recovery from psychosis. Schizophr Bull (1989) 0.87
Effect of sequential mestranol-chlormadinone on sebum production. Arch Dermatol (1967) 0.87
Work and mental illness. I. Toward an integration of the rehabilitation process. J Nerv Ment Dis (1987) 0.87
Diagnostic models and the nature of psychiatric disorder. Arch Gen Psychiatry (1973) 0.86
A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat (2001) 0.86
Sebaceous gland response in man to prolonged total caloric deprivation. J Invest Dermatol (1970) 0.86
Skin lipids: an update. J Invest Dermatol (1987) 0.86
The effect of accumulated lipids on measurements of sebum secretion in human skin. J Invest Dermatol (1982) 0.86
The prognosis of schizophrenia: rationale for a multidimensional concept. Schizophr Bull (1978) 0.86
Borderline and schizophrenic patients: A comparative study. Am J Psychiatry (1975) 0.85
Ketoconazole and the liver. J Am Acad Dermatol (1982) 0.85
Identification of a fatty acid in human skin surface lipids apparently associated with acne vulgaris. J Invest Dermatol (1973) 0.85
Sebaceous gland activity in breast cancer. Nature (1968) 0.85
Effect of oral and topical 17-alpha-methyl-B-nortestosterone on sebum production and plasma testosterone. J Invest Dermatol (1969) 0.85
Recovery from delusions. Three phases documented by patient's interpretation of research procedures. Arch Gen Psychiatry (1974) 0.85
Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment. Arch Dermatol (1976) 0.85
On the mechanism of sebaceous secretion. Arch Dermatol Res (1982) 0.84
A primer on cosmetics. AAD Advisory Board, CTFA Task Force on Cosmetics. J Am Acad Dermatol (1992) 0.84
Changes in skin surface lipid composition induced by severe caloric restriction in man. Am J Clin Nutr (1972) 0.84
Skin surface lipid composition, acne, pubertal development, and urinary excretion of testosterone and 17-ketosteroids in children. J Invest Dermatol (1977) 0.84
Computerised life chart methods to map domains of function and illustrate patterns of interactions in the long-term course trajectories of patients who once met the criteria for DSM-III schizophrenia. Br J Psychiatry Suppl (1989) 0.83
Plasma testosterone and estrogen levels, urine testosterone excretion, and sebum production in males with acne vulgaris. J Clin Endocrinol Metab (1965) 0.82
The diagnosis and understanding of schizophrenia. Part I. Use of signs and symptoms for the identification of schizophrenic patients. Schizophr Bull (1974) 0.82
Evaluating signs and symptoms: comparison of structured interview ans clinical approaches. Br J Psychiatry (1976) 0.82
Skin lipids. Comp Biochem Physiol B (1983) 0.81
Changes in sebum secretion and the sebaceous gland. Clin Geriatr Med (1989) 0.81
"Virtual microscopy" and the internet as telepathology consultation tools: diagnostic accuracy in evaluating melanocytic skin lesions. Am J Dermatopathol (1999) 0.81
Measurement of the time between synthesis and surface excretion of sebaceous lipids in sheep and man. J Invest Dermatol (1975) 0.81
Acne: perspectives. J Invest Dermatol (1974) 0.81
The low turning point. A control mechanism in the course of mental disorder. J Nerv Ment Dis (1989) 0.81
What does rehabilitation accomplish? Schizophr Bull (1986) 0.80
Lipid composition of cultured murine keratinocytes. J Invest Dermatol (1986) 0.80
Sebaceous gland activity in black skin. Dermatol Clin (1988) 0.80
Premorbid adjustment in schizophrenia: concepts, measures, and implications. Part I. The concept of premorbid adjustment. Schizophr Bull (1977) 0.80
Pendulum eye-tracking in remitted psychiatric patients. J Psychiatr Res (1978) 0.80
The fatty acids of human sebaceous gland phosphatidylcholine. Biochim Biophys Acta (1978) 0.80